Actively Recruiting

Age: 18Years +
FEMALE
NCT06511167

Post-market Surveillance Study to Evaluate the Quality of Life and the Safety and Effectiveness of the TIGR® Matrix After Reconstructive Breast Surgery

Led by AWOgyn · Updated on 2026-05-11

135

Participants Needed

5

Research Sites

216 weeks

Total Duration

On this page

Sponsors

A

AWOgyn

Lead Sponsor

E

Esculape GmbH

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this observational study is to evaluate the quality of life of participants who have undergone implant-based breast surgery. This will be done using the BREAST-Q questionnaire. The study also aims to demonstrate that the fully resorbable TIGR® Matrix is safe and effective.

CONDITIONS

Official Title

Post-market Surveillance Study to Evaluate the Quality of Life and the Safety and Effectiveness of the TIGR® Matrix After Reconstructive Breast Surgery

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women with confirmed breast cancer, precancerous conditions, genetic risk, or family history with indication for skin sparing or nipple sparing mastectomy, or prophylactic operation
  • ECOG performance status 0 to 2
  • Decision to use TIGR4 Matrix made before and independent of study enrollment
  • Mentally able to understand the study's nature, aims, and possible consequences
  • Provided signed informed consent
  • At least 18 years old
Not Eligible

You will not qualify if you...

  • Pregnancy or breastfeeding
  • Known intolerance to the TIGR4 Matrix or similar mesh implants
  • Metastatic breast cancer with life expectancy less than 5 years
  • Poorly controlled diabetes
  • Low bone marrow function with neutrophil granulocytes below 1500 and platelets below 100,000/�b5l
  • Withdrawal or lack of written informed consent
  • Non-compliance with data collection, treatment, or follow-up
  • Institutionalized by court or official order
  • Participation in another surgical clinical trial affecting surgical technique or outcomes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

GRN-Klinik Weinheim

Weinheim, Baden-Wurttemberg, Germany, 69469

Active, Not Recruiting

2

Klinik und Poliklinik für Frauenheilkunde Technische Universität München

München, Bavaria, Germany, 80337

Actively Recruiting

3

Agaplesion Markus Krankenhaus Frankfurt

Frankfurt am Main, Hesse, Germany, 60431

Actively Recruiting

4

Evangelisches Krankenhaus Wesel

Wesel, North Rhine-Westphalia, Germany, 46485

Actively Recruiting

5

Krankenhaus St. Elisabeth und St. Barbara Halle (Saale) GmbH

Halle, Germany, 06110

Actively Recruiting

Loading map...

Research Team

M

Marc Thill, Prof.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here